NUR 6011 Exam 1 Actual Exam V2 | NUR 6011 Advance Pharmacology
(NUR6011 Exam 1) | William Paterson University
1. A patient is prescribed a medication that is a known substrate of the CYP3A4 enzyme
system. If the patient starts consuming grapefruit juice daily, what is the most likely
pharmacological outcome?
A. Increased plasma levels of the drug leading to potential toxicity.
B. Decreased plasma levels of the drug due to induction.
C. Reduced bioavailability due to increased first-pass metabolism.
D. Enhanced renal excretion of the drug metabolites.
Answer: A
Rationale: Grapefruit juice acts as an inhibitor of the CYP3A4 enzyme in the intestinal wall.
By inhibiting this enzyme, the metabolism of substrate drugs is slowed, leading to higher
systemic concentrations. This increase in plasma levels significantly raises the risk of
adverse effects and toxicity for the patient.
2. Which pharmacokinetic process is most significantly affected by a patient’s low serum
albumin level?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Serum albumin is the primary protein responsible for drug binding in the
plasma, which directly influences the distribution of highly protein-bound medications.
When albumin levels are low, there is more free, active drug available to move into tissues
or produce a therapeutic effect. This physiological change requires the clinician to monitor
for increased drug activity and potential toxicity.
3. An Advanced Practice Nurse (APN) is prescribing a drug with a narrow therapeutic index.
Which of the following is the most important consideration?
A. The drug is inherently safe and requires little monitoring.
B. The drug’s half-life is extremely short, preventing accumulation.
C. The drug has a high margin of safety for the general population.
D. The difference between a therapeutic dose and a toxic dose is small.
,Answer: D
Rationale: A narrow therapeutic index indicates that the range between the effective dose
and the lethal or toxic dose is very slim. For these medications, small changes in blood
concentration can lead to significant clinical consequences. Therefore, rigorous therapeutic
drug monitoring is essential to ensure patient safety and efficacy.
4. When determining the dosing interval for a medication, the prescriber understands that
‘steady state’ is typically reached after how many half-lives?
A. 1 to 2 half-lives
B. 4 to 5 half-lives
C. 2 to 3 half-lives
D. 8 to 10 half-lives
Answer: B
Rationale: Steady state occurs when the rate of drug administration equals the rate of drug
elimination. It generally takes approximately four to five half-lives of consistent dosing to
achieve this equilibrium. Understanding this timing is crucial for evaluating the full
therapeutic effect of a new medication or dose adjustment.
5. A drug that binds to a receptor and produces a maximal biological response is categorized
as a:
A. Partial agonist
B. Full agonist
C. Antagonist
D. Inverse agonist
Answer: B
Rationale: A full agonist possesses high affinity for a receptor and high intrinsic activity,
allowing it to trigger a maximum response. This is contrasted with partial agonists, which
can only produce a sub-maximal response regardless of concentration. Recognizing these
differences helps the APN predict the clinical intensity of various pharmacotherapeutic
agents.
6. Which physiological change in the geriatric population is most likely to increase the half-life
of lipid-soluble drugs?
A. Increased percentage of body fat
B. Decreased percentage of body fat
C. Increased total body water
, D. Increased hepatic blood flow
Answer: A
Rationale: As patients age, they typically experience an increase in adipose tissue and a
decrease in lean body mass and water. Lipid-soluble drugs are distributed more widely into
this increased fat, which increases the volume of distribution. Consequently, the drug
remains in the body longer, prolonging its half-life and increasing the risk of cumulative
toxicity.
7. The ‘first-pass effect’ refers to which of the following?
A. The time it takes for a drug to reach the peak plasma concentration.
B. The binding of a drug to receptors in the gastrointestinal tract.
C. The excretion of a drug through the kidneys on the first cycle.
D. Metabolism of a drug by the liver before it reaches systemic circulation.
Answer: D
Rationale: The first-pass effect occurs when an orally administered drug is absorbed from
the GI tract and carried via the portal vein to the liver. The liver metabolizes a portion of
the drug before it can ever reach the heart and systemic circulation. This process effectively
reduces the bioavailability of the drug, often requiring higher oral doses compared to
parenteral routes.
8. Which of the following is a primary characteristic of a Schedule II controlled substance?
A. High potential for abuse, with use leading to severe physical or psychological
dependence.
B. No currently accepted medical use in the United States.
C. Low potential for abuse relative to Schedule III substances.
D. May be refilled up to five times in a six-month period.
Answer: A
Rationale: Schedule II drugs have a high potential for abuse and dependence but do have
currently accepted medical applications. These medications are subject to strict prescribing
regulations, such as no refills and the requirement for a written or secure electronic
prescription. APNs must adhere to these federal and state guidelines to prevent diversion
and patient harm.
9. A patient with chronic kidney disease (CKD) requires an antibiotic that is primarily excreted
renally. How should the APN adjust the prescription?
A. Increase the dose to compensate for poor filtration.
B. Switch to a drug that is more highly protein-bound.
(NUR6011 Exam 1) | William Paterson University
1. A patient is prescribed a medication that is a known substrate of the CYP3A4 enzyme
system. If the patient starts consuming grapefruit juice daily, what is the most likely
pharmacological outcome?
A. Increased plasma levels of the drug leading to potential toxicity.
B. Decreased plasma levels of the drug due to induction.
C. Reduced bioavailability due to increased first-pass metabolism.
D. Enhanced renal excretion of the drug metabolites.
Answer: A
Rationale: Grapefruit juice acts as an inhibitor of the CYP3A4 enzyme in the intestinal wall.
By inhibiting this enzyme, the metabolism of substrate drugs is slowed, leading to higher
systemic concentrations. This increase in plasma levels significantly raises the risk of
adverse effects and toxicity for the patient.
2. Which pharmacokinetic process is most significantly affected by a patient’s low serum
albumin level?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Serum albumin is the primary protein responsible for drug binding in the
plasma, which directly influences the distribution of highly protein-bound medications.
When albumin levels are low, there is more free, active drug available to move into tissues
or produce a therapeutic effect. This physiological change requires the clinician to monitor
for increased drug activity and potential toxicity.
3. An Advanced Practice Nurse (APN) is prescribing a drug with a narrow therapeutic index.
Which of the following is the most important consideration?
A. The drug is inherently safe and requires little monitoring.
B. The drug’s half-life is extremely short, preventing accumulation.
C. The drug has a high margin of safety for the general population.
D. The difference between a therapeutic dose and a toxic dose is small.
,Answer: D
Rationale: A narrow therapeutic index indicates that the range between the effective dose
and the lethal or toxic dose is very slim. For these medications, small changes in blood
concentration can lead to significant clinical consequences. Therefore, rigorous therapeutic
drug monitoring is essential to ensure patient safety and efficacy.
4. When determining the dosing interval for a medication, the prescriber understands that
‘steady state’ is typically reached after how many half-lives?
A. 1 to 2 half-lives
B. 4 to 5 half-lives
C. 2 to 3 half-lives
D. 8 to 10 half-lives
Answer: B
Rationale: Steady state occurs when the rate of drug administration equals the rate of drug
elimination. It generally takes approximately four to five half-lives of consistent dosing to
achieve this equilibrium. Understanding this timing is crucial for evaluating the full
therapeutic effect of a new medication or dose adjustment.
5. A drug that binds to a receptor and produces a maximal biological response is categorized
as a:
A. Partial agonist
B. Full agonist
C. Antagonist
D. Inverse agonist
Answer: B
Rationale: A full agonist possesses high affinity for a receptor and high intrinsic activity,
allowing it to trigger a maximum response. This is contrasted with partial agonists, which
can only produce a sub-maximal response regardless of concentration. Recognizing these
differences helps the APN predict the clinical intensity of various pharmacotherapeutic
agents.
6. Which physiological change in the geriatric population is most likely to increase the half-life
of lipid-soluble drugs?
A. Increased percentage of body fat
B. Decreased percentage of body fat
C. Increased total body water
, D. Increased hepatic blood flow
Answer: A
Rationale: As patients age, they typically experience an increase in adipose tissue and a
decrease in lean body mass and water. Lipid-soluble drugs are distributed more widely into
this increased fat, which increases the volume of distribution. Consequently, the drug
remains in the body longer, prolonging its half-life and increasing the risk of cumulative
toxicity.
7. The ‘first-pass effect’ refers to which of the following?
A. The time it takes for a drug to reach the peak plasma concentration.
B. The binding of a drug to receptors in the gastrointestinal tract.
C. The excretion of a drug through the kidneys on the first cycle.
D. Metabolism of a drug by the liver before it reaches systemic circulation.
Answer: D
Rationale: The first-pass effect occurs when an orally administered drug is absorbed from
the GI tract and carried via the portal vein to the liver. The liver metabolizes a portion of
the drug before it can ever reach the heart and systemic circulation. This process effectively
reduces the bioavailability of the drug, often requiring higher oral doses compared to
parenteral routes.
8. Which of the following is a primary characteristic of a Schedule II controlled substance?
A. High potential for abuse, with use leading to severe physical or psychological
dependence.
B. No currently accepted medical use in the United States.
C. Low potential for abuse relative to Schedule III substances.
D. May be refilled up to five times in a six-month period.
Answer: A
Rationale: Schedule II drugs have a high potential for abuse and dependence but do have
currently accepted medical applications. These medications are subject to strict prescribing
regulations, such as no refills and the requirement for a written or secure electronic
prescription. APNs must adhere to these federal and state guidelines to prevent diversion
and patient harm.
9. A patient with chronic kidney disease (CKD) requires an antibiotic that is primarily excreted
renally. How should the APN adjust the prescription?
A. Increase the dose to compensate for poor filtration.
B. Switch to a drug that is more highly protein-bound.
